Effects of Serum on In Vitro Susceptibility Testing of Echinocandins

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

The effects of protein binding on the activities of caspofungin, anidulafungin, and micafungin were evaluated against Candida and Aspergillus species. Adding human serum sharply increased the MICs of micafungin and anidulafungin and modestly affected the MIC of caspofungin. The increase in MICs does not appear consistent with the rate of protein binding for the three compounds.

Knowledge Graph

Similar Paper

Effects of Serum on In Vitro Susceptibility Testing of Echinocandins
Antimicrobial Agents and Chemotherapy 2007.0
Serum Differentially Alters the Antifungal Properties of Echinocandin Drugs
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Activities of Echinocandins againstCandida kruseiDetermined by Three Methods: MIC and Minimal Fungicidal Concentration Measurements and Time-Kill Studies
Antimicrobial Agents and Chemotherapy 2009.0
Antifungal Activity of Micafungin in Serum
Antimicrobial Agents and Chemotherapy 2009.0
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
Antimicrobial Agents and Chemotherapy 2010.0
Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Fungicidal Activities of Echinocandins against Candida metapsilosis , C. orthopsilosis , and C. parapsilosis Evaluated by Time-Kill Studies
Antimicrobial Agents and Chemotherapy 2010.0
Comparative In Vitro Activities of Caspofungin and Micafungin, Determined Using the Method of the European Committee on Antimicrobial Susceptibility Testing, against Yeast Isolates Obtained in France in 2005-2006
Antimicrobial Agents and Chemotherapy 2008.0
Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences
Antimicrobial Agents and Chemotherapy 2007.0
Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds
Antimicrobial Agents and Chemotherapy 2009.0